Literature DB >> 18508839

A microcosting study of intensive care unit stay in the Netherlands.

Siok Swan Tan1, Leona Hakkaart-van Roijen, Maiwenn J Al, Clazien A Bouwmans, Marga E Hoogendoorn, Peter E Spronk, Jan Bakker.   

Abstract

The primary objective of this study was to estimate the actual daily costs of intensive care unit stay using a microcosting methodology. As a secondary objective, the degree of association between daily intensive care unit costs and some patient characteristics was examined. This multicenter, retrospective cost analysis was conducted in the medical-surgical adult intensive care units of 1 university and 2 general hospitals in the Netherlands for 2006, from a hospital perspective. A total of 576 adult patients were included, consuming a total of 2868 nursing days. The mean total costs per intensive care unit day were 1911, with labour (33%) and indirect costs (33%) as the most important cost drivers. An ordinary least squares analysis including age, Nine Equivalent of Nursing Manpower Use score/Therapeutic Intervention Scoring System score, mechanical ventilation, blood products, and renal replacement therapy was able to predict 50% of the daily intensive care unit costs.

Entities:  

Mesh:

Year:  2008        PMID: 18508839     DOI: 10.1177/0885066608318661

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  13 in total

1.  Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence.

Authors:  Chantal W M van Gils; Saskia de Groot; William K Redekop; Miriam Koopman; Cornelis J A Punt; Carin A Uyl-de Groot
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

2.  Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck.

Authors:  N van der Linden; C W M van Gils; C P Pescott; J Buter; M R Vergeer; C A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-19       Impact factor: 2.503

3.  Health economic modeling of the potential cost saving effects of Neurally Adjusted Ventilator Assist.

Authors:  Jonas Hjelmgren; Sara Bruce Wirta; Pernilla Huetson; Karl-Johan Myrén; Sylvia Göthberg
Journal:  Ther Adv Respir Dis       Date:  2015-09-30       Impact factor: 4.031

Review 4.  Economics of ICU organization and management.

Authors:  Hannah Wunsch; Hayley Gershengorn; Damon C Scales
Journal:  Crit Care Clin       Date:  2011-10-22       Impact factor: 3.598

5.  Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter randomized controlled trial based on US costs.

Authors:  Gordon S Doig; Fiona Simpson
Journal:  Clinicoecon Outcomes Res       Date:  2013-07-22

6.  Early enteral nutrition in critical illness: a full economic analysis using US costs.

Authors:  Gordon S Doig; Hélène Chevrou-Séverac; Fiona Simpson
Journal:  Clinicoecon Outcomes Res       Date:  2013-08-23

7.  Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands.

Authors:  Maiwenn J Al; Leona Hakkaart; Siok Swan Tan; Jan Bakker
Journal:  Crit Care       Date:  2010-11-01       Impact factor: 9.097

8.  Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation.

Authors:  Heidi Turunen; Stephan M Jakob; Esko Ruokonen; Kirsi-Maija Kaukonen; Toni Sarapohja; Marjo Apajasalo; Jukka Takala
Journal:  Crit Care       Date:  2015-02-19       Impact factor: 9.097

9.  Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.

Authors:  Naomi van der Linden; Jan Buter; Chris P Pescott; Roy I Lalisang; Jan Paul de Boer; Alexander de Graeff; Carla M L van Herpen; Robert J Baatenburg de Jong; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-21       Impact factor: 2.503

10.  Selective decontamination of the digestive tract and selective oropharyngeal decontamination in intensive care unit patients: a cost-effectiveness analysis.

Authors:  Evelien A N Oostdijk; G A de Wit; Marina Bakker; Anne Marie G A de Smet; M J M Bonten
Journal:  BMJ Open       Date:  2013-03-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.